MARKET

AZN

AZN

AstraZeneca
NYSE
187.99
-5.04
-2.61%
Opening 14:50 02/09 EST
OPEN
191.84
PREV CLOSE
193.03
HIGH
191.87
LOW
187.46
VOLUME
2.11M
TURNOVER
--
52 WEEK HIGH
195.00
52 WEEK LOW
123.36
MARKET CAP
291.56B
P/E (TTM)
31.23
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at AZN last week (0202-0206)?
Weekly Report · 17h ago
Oakmark International Strategy Q4 2025 New Investments And Divestments
Seeking Alpha · 1d ago
Earnings week ahead: F, KO, CSCO, SHOP, MCD, BP, AMAT, COIN, MRNA, ROKU, and more
Seeking Alpha · 1d ago
Wall Street Week Ahead
Seeking Alpha · 1d ago
Spotlight On Coca-Cola, Ford, AstraZeneca Earnings
Seeking Alpha · 2d ago
CVS pharmacies accepting TrumpRx discount cards
Seeking Alpha · 3d ago
AstraZeneca price target raised to 11,500 GBp from 11,000 GBp at Deutsche Bank
TipRanks · 3d ago
AstraZeneca’s TAPER Study Targets Simpler Severe Asthma Care With Tezepelumab
TipRanks · 3d ago
More
About AZN
AstraZeneca PLC is a United Kingdom-based science-led biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of prescription medicines. The Company operates across therapy areas, including Oncology; Cardiovascular, Renal and Metabolism (CVRM); Respiratory and Immunology (R&I); Vaccines and Immune Therapies (V&I), and Rare Disease. In the Oncology area, its key products include Tagrisso, Imfinzi, Calquence, Lynparza, and Enhertu. The key products of CVRM area include Farxiga/Forxiga, Brilinta/Brilique, Crestor, and Lokelma. In the R&I area, the key products are Symbicort, Fasenra, Breztri/Trixeo, and Tezspire. In the V&I Therapies area, the products are Beyfortus and FluMist. The products in the Rare Disease area are Ultomiris, Soliris, Strensiq, and Koselugo. It has about 191 projects in its development pipeline, including 19 new molecular entities (NMEs) in the late-stage pipeline. The Company distributes its products in over 125 countries.

Webull offers AstraZeneca plc stock information, including NYSE: AZN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AZN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AZN stock methods without spending real money on the virtual paper trading platform.